Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.

ABSTRACT:

Context

Anxiety and depression are the most commonly reported psychiatric conditions and frequently occur as comorbid disorders. While the advent of conventional drug therapies has simplified treatment, a large segment of the population goes untreated or declines conventional therapy for financial, cultural, or personal reasons. Therefore, the identification of inexpensive and effective alternative therapies for anxiety and depression is of relevance to public health.

Objective

The current study explores data from a 2009 clinical chamomile trial in humans to determine if chamomile provides clinically meaningful antidepressant activity versus a placebo.

Design

In the 2009 randomized, double-blind, placebo-controlled study, the research team examined the antianxiety and

SUBMITTER: Amsterdam JD 

PROVIDER: S-EPMC3600408 | biostudies-literature | 2012 Sep-Oct

REPOSITORIES: biostudies-literature